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A B S T R A C T   
Tracheal granular cell tumors are rare neurogenic neoplasms characterized by an indolent behavior. We report 
the case of a young woman affected by this tumor with non-specific clinical presentation. We performed a 
literature search in order to identify all the cases of tracheal granular cell tumor and to summarize the current 
state of knowledge about this rare disease.   
1. Introduction 
Granular cell tumors (GCT) are rare tumors of neurogenic origin [1]. 
Although these neoplasms can occur in any part of the body, GCTs are 
rarely reported in the laryngotracheal region [2]. In tracheal GCTs, 
treatment can vary from simple observation to tracheal resection or 
endoscopic excision assisted by laser, electrosurgery or argon plasma 
coagulation [3]. In this study, we present the case of a woman affected 
by tracheal GCT who presented with acute dyspnea. We conducted a 
literature search and we found 42 cases of GCT of the trachea including 
clinical, epidemiological and therapeutic characteristics, summarizing 
the current state of knowledge about this rare tumor. 
2. Case presentation 
A 42-year-old former smoker woman (30 pack-years) presented to 
the Emergency Department with acute onset of dyspnea, cough and 
fever. The patient had no comorbidities and the physical exam was 
within normal limits. In order to exclude a pulmonary thromboembo-
lism, a computed tomography angiography was performed, revealing 
bilateral hilar and mediastinal lymphadenopathy and various areas of 
ground glass of both the inferior lobes. Several blood tests were done in 
order to exclude an infectious disease; the tests were negative, including 
QuantiFERON-TB Gold test. Bronchoscopy showed a marked thickening 
of the tracheal carina extending for a few millimeters to the medial 
aspect of both mainstem bronchi (Fig. 1). 
Histopathology examination of the bronchial biopsies performed in 
this area revealed sheets of epithelioid cells with eosinophilic granular 
cytoplasm, positive for S100 and NSE and negative for CAM5.2 (Fig. 2; 
Fig. 3), consistent with a diagnosis of GCT. An endobronchial 
ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) of the 
lymph node stations #4R, #7 and #11Rs was performed and the cyto-
pathological examination suggested their “reactive” nature by showing 
a predominance of lymphocytes. Culture of bronchoalveolar lavage 
(BAL) for common bacteria, fungi and mycobacteria proved negative. 
The tumor was ablated with Nd:YAG laser (Fig. 4) during rigid bron-
choscopy under general anesthesia and the patient is currently free of 
disease 12 months after treatment. 
3. Discussion 
GCTs (also known as Abrikossoff tumors) were reported by Weber in 
1854 [4] and later described by Abrikossoff in 1926 [5]. They were 
originally considered muscle tumors and called myoblastomas on the 
basis of a supposed myogenic origin. Due to their ultrastructural and 
immunohistochemical characteristics, in the last 30 years GCTs have 
been identified as neural lesions deriving from Schwann cells [1]. These 
neoplasms are characterized by a very slow growth rate and a benign 
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behavior, reported in up to the 98% of cases; cases of malignant GCTs 
have been documented in literature although none of these variants 
have never been reported in trachea [6]. GCTs usually involve skin, 
breast and especially the gastrointestinal tract (e.g. oral cavity, tongue 
and esophagus) although they can occur anywhere in the body [7]. GCTs 
represent a very rare finding in the respiratory tract, particularly in the 
laryngotracheal region [8] as evidenced by the only 42 cases, including 
our patient, of tracheal GCTs reported in literature up to now. 
We performed a literature search for the present study. The search 
included PubMed, EMBASE and Google Scholar, and used the following 
search terms: “tracheal granular cell tumor”, “granular cell tumor”, 
“rare airway tumors”, “tracheal malignancies”. The inclusion criteria 
were as follows: all types of articles, articles published in PubMed and 
related only to humans. Articles for which full text was not available 
were excluded. The Medline search of GCT of the trachea found alto-
gether 41 cases. Overall, forty-two cases of GCT have been identified. 
The clinical and pathological findings of all cases are summarized in 
Table 1. The age range was 6–64 years, with a mean and a median age of 
33 years and 32 years, respectively. Thirty-five of 42 (83,3%) patients 
were women and 22 of 30 (73,3%) were of African or African American 
origin and 2 patients were Asians. The mean size of the neoplasm at the 
time of diagnosis was 2.27 cm, with a range from 0.45 to 6 cm in its large 
axis. Seven of 42 (16,7%) of the reported cases of GCTs were multiple. As 
regards the site, 15 of 42 tumors were intrathoracic, 26 cervical. In one 
case, GTCs were both cervical and intrathoracic in location. Our search 
listed 31 intraluminal neoplasms and 8 extraluminal. Three of 42 tumors 
were both intraluminal and extraluminal. Twenty-four of 42 patients 
received tracheal resection while 7 tumors were endoscopically excised. 
One patient was treated with external beam radiation. Of the 24 tracheal 
resections, no recurrences have been reported; the rate of recurrence in 
endoscopically resected patients was 29%, with 2 of 7 cases. Of the 24 
GCTs treated with tracheal resection, 3 patients (12,5%) died for post-
operative complications. Five of 24 patients who underwent tracheal 
resection also received thyroid lobectomy; two cases were treated with 
electrosurgery and argon plasma coagulation. 
As stated before, median age at diagnosis of tracheal GCTs appears to 
be around 33 years, with a higher incidence in African and African 
American women (Table 2). Nevertheless, there are some remarkable 
exceptions to this general rule, as indicated by several cases of tracheal 
GCTs in pediatric age [9,10]. No specific risk factors are currently linked 
to the diagnosis of tracheal GCT although in most cases active smoking 
or a history of smoking is reported [11]. Most GCTs are found in females 
supporting a hormonal relationship between gender and disease [12]. 
Because of the small number of patients and the missing data, it is not 
possible to determine an established and definitive correlation between 
hormonal factors and tracheal GCTs although the incidence of GCT in 
hyperestrogenic state is reported by several authors [13–15]. Our search 
could support this correlation between gender and tracheal GCT since 
the 85,4% of patients affected are female. 
These neoplasms are asymptomatic in the vast majority of patients 
[11]. Clinical features associated with tracheal GCTs include, if present, 
signs and symptoms such as persistent cough, hemoptysis, wheezing, 
obstructive sleep apnea and progressive dyspnea unresponsive to 
beta-2-agonists, glucocorticoids and anticholinergic agents [3]. The 
initial diagnostic assessment should include a careful patient history and 
physical examination; many of the tracheal GCTs are diagnosed inci-
dentally on computed tomography (CT) scan or bronchoscopy. Recently, 
an Italian study focused on the specific pattern of tracheal GCT in 
multidetector computed tomography scan (MDCT) [16], suggesting that 
these neoplasms appear to have smooth margins and no sign of invasion 
at the CT scan imaging without contrast administration. On the other 
hand, multiphase study shows elevated contrast enhancement in arterial 
phase and a modest release in venous phase, underlining important 
differences with other benign tracheal tumors [16]. Endoscopic exami-
nations such as laryngoscopy and bronchoscopy are the diagnostic 
modalities of choice as they allow for direct visualization for localiza-
tion, tumor size, luminal status and tissue sampling. Macroscopically, 
tracheal GCTs appear more frequently as pedunculated polypoid lesion 
with intact mucosa partially obstructing the tracheal lumen [17]. From a 
histopathological point of view, GCTs are composed of large round 
monomorphic cells with eosinophilic and granular cytoplasm [18]; 
tumor cells usually show a tendency to aggregate in nests without evi-
dence of necrosis or vascular invasion. Immunohistochemically, the 
Fig. 1.  
Fig. 2. H&E staining reveal large cells with cytoplasmic granules.  
Fig. 3. Immunohistochemical staining: tumor cells positive for NSE, S-100 
and CD68. 
Fig. 4.  
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expression of S-100 protein and neuron-specific enolase (NSE) is crucial 
for reaching a definitive diagnosis [19,20]. Tumor cells often express 
also laminin, HLA-DR, CD56, CD57, CD68 and several myelin proteins 
[19]; immunohistochemical staining is typically negative for smooth 
muscle, calretinin and inhibin [20]. 
Treatments in tracheal GCT include tracheal resection, or endoscopic 
removal assisted by laser, electrosurgery or argon plasma coagulation 
[16]. As stated by our search, tracheal resection seems to be particularly 
effective but the high postoperative mortality rate severely limits its use; 
on the contrary, endoscopic excision appears to have a not insignificant 
recurrence rate in absence of perioperative mortality [3]. The need for a 
radical surgery often includes thyroid lobectomy according to the 
extension and the involvement of the paratracheal region. Very few data 
are currently available about the use of laser excision. Given the limited 
data, a reasonable approach could include endoscopic treatment as 
initial treatment of choice and tracheal resection in case of recurrent 
disease or large lesions threatening airway patency. No data are 
currently available in literature about the use of chemotherapy in 
tracheal GCTs and no cases of metastasized tracheal GCT have never 
been reported, further emphasizing the indolent behavior of the disease. 
As regards the follow-up program, annual CT scans and endoscopic ex-
aminations may be recommended although the rarity of the disease and 
the lack of data about recurrence rate do not permit to define unam-
biguous recommendations. 
4. Conclusion 
We herein report a case of tracheal GCT in a young woman 
Table 1 
Published data about Tracheal Granular Cell Tumors.  
Source Age Sex Race Size 
(cm) 
Solitary/ 
Multiple 
Location Intra/ 
extraluminal 
Therapy Results/Follow-up 
Archer 56 F Black 2.8 S Intrathoracic Intra Tracheal resection Died postoperatively 
Benson 22 F NA 0.5 M Intrathoracic Intra Endoscopic excision Residual disease/8 
months 
Vance NA NA NA NA S Intrathoracic Intra Endoscopic excision NED/7 months 
Sargent 50 F Black NA S Intrathoracic Intra Radiation therapy DWD/5 months 
Benisch [15] 25 F Black 1.5 S Cervical Intra Tracheal resection NED/15 months 
Krouse 54 F Black 2.5; 
0.5 
M Cervical and intrathoracic Extra None Postmortem finding 
Thawley 33 F Black NA S Cervical Extra Thyroid lobectomy, tracheal 
wall shaving 
Residual disease/8 
years 
Carnalis 45 F NA 5.5 S Cervical with posterior 
wall erosion 
Intra and extra Tracheal resection NED/3 years 
Frable 38 F Black NA S Cervical Intra Endoscopic excision NED/5 years 
O’Connell 36 F Black NA M Cervical Intra Tracheal resection Died postoperatively 
Polack 29 F Black 2 S Cervical Extra Local excision, tracheal shaving NED/4 weeks 
Subbuswamy 35 F Black 2.5 S Intrathoracic Intra None Postmortem finding 
Daniel 31 F NA 1.5 S Intrathoracic Intra Tracheal resection NED/4 months 
Dunaway 6 F Black 2 M Cervical Intra Endoscopic excision Residual disease/9 
years 
Cech 41 M White 1.5 S Intrathoracic Intra Tracheal resection NED/6 years 
McLain 26 M Black 2 M Cervical Intra Tracheal resection NED/9 months 
Mikaelian 20 F Black 2 S Cervical Intra Tracheal resection NED/2 years 
Mikaelian 30 F Black 3 S Intrathoracic Intra Tracheal resection NED/5 years 
Thaller 31 F Black 6 S Cervical Intra Endoscopic excision NED/6 weeks 
Muthuswamy 26 F Black 2 S Intrathoracic Intra Tracheal resection NED/1 year 
Alessi 33 F NA NA S Cervical Extra Partial tracheal resection NED/7 years 
Alessi 37 F NA 3 S Cervical Intra Tracheal resection, thyroid 
lobectomy 
NED/2 years 
Solomons 10 M NA NA S Cervical Intra Partial tracheal resection Died postoperatively 
Burton [9] 14 F Black NA M Cervical Intra Tracheal resection NED/4 months 
Burton [9] 38 F White NA S Intrathoracic Intra Tracheal resection NED/1 year 
Burton [9] 37 F Black 3 S Cervical Extra Partial tracheal resection, 
thyroid lobectomy 
NED/1 year 
Burton [9] 19 F NA 1.5 S Cervical Intra Endoscopic excision NED/8 years 
Burton [9] 43 F Black 4 S Cervical Intra and extra Tracheal resection, thyroid 
lobectomy 
NED/6 months 
Burton [9] 25 M Black 1.5 S Intrathoracic Intra Tracheal resection NED/2 years 
Spandow [10] 12 M NA NA S Cervical Intra Tracheal resection NED/18 months 
Thomas 46 F NA 0.45 M Cervical Intra and extra Tracheal resection NA 
Raymond 50 M Black 4.8 S Intrathoracic Extra Tracheal resection NED/20 months 
Frenckner 28 F White NA S Cervical Intra Transtracheal enucleation NED/3 years 
Desai [1] 10 F NA NA S Cervical Intra Tracheal excision NED/10 years 
Kintanar [13] 35 F NA 2.2 S Cervical Extra Partial tracheal resection, 
thyroid lobectomy 
NA 
Ipakchi [3] 22 F Black 3 S Cervical Intra Endoscopic resection NED/18 months 
Lee [8] 45 F Asian 3 S Cervical Extra Tracheal resection, thyroid 
lobectomy 
NED/13 months 
Guarnieri 
[16] 
64 F White 1.3 S Cervical Intra Electrosurgery and argon 
plasma coagulation 
NA 
Bekteshi [11] 37 F Black 0.6 S Intrathoracic Intra Electrosurgery and argon 
plasma coagulation 
NED/3 months 
Joung [20] 20 F Asian NA S Intrathoracic Intra None NED/2 years 
Stieglitz 14 F White 1.5 S Cervical Intra Tracheal resection NED/3 years 
Current study 42 F White 0.5 S Intrathoracic Intra Nd: YAG laser ablation NED/1 year 
NA: not available; F: female; M: male; S: solitary; M: multiple; Intra: intraluminal; Extra: extraluminal; NED: no evidence of disease; DWD: died with disease. 
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presenting with dyspnea. Diagnosis of tracheal GCT requires a high 
index of suspicion given a clinical presentation which often mimics 
typical signs and symptoms of bronchial asthma or recurrent pneu-
monia, as in our case. We encourage the need for large case series in 
order to provide further information concerning tracheal GCTs, taking 
into account the paucity of data currently available in literature and the 
extreme rarity of the disease. 
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Table 2 
Summary of chief characteristics of tracheal GCTs.  
Histologic origin Mesenchymal (Neurogenic origin from Schwann 
cell) 
Histologic characteristics Large round monomorphic cells with prominent 
granular eosinophilic cytoplasm 
Immunohistochemical 
analysis 
Stain positive for S-100 and NSE, negative for 
smooth muscle, calretinin and inhibin 
Etiology Idiopathic (hypothesized role of smoke and 
estrogen state) 
Differential diagnosis Benign tracheal tumors, malignant tracheal 
tumors, esophageal tumors, thyroid tumors, 
COPD, bronchial asthma 
Incidence Extremely rare, 42 cases reported in literature 
Age predilection Third decade of life 
Gender predilection Female 
Race predilection African and African American 
Clinical features Persistent cough, hemoptysis, wheezing, 
expiratory stridor, obstructive sleep apnea and 
progressive dyspnea 
CT scan imaging Smooth and well-defined margins, elevated 
contrast enhancement in arterial phase and 
modest release of contrast in venous phase 
Laryngoscopy and rigid 
bronchoscopy 
Pedunculated polypoid lesion partially 
obstructing the lumen 
Treatment Surgery (tracheal resection, endoscopic excision, 
electrosurgery with argon plasma coagulation) 
Prognosis Good, primarily affected by airway patency and 
treatment 
Follow-up Annual CT scan and endoscopic examination  
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